These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Targeted lung cancer screening selects individuals at high risk of cardiovascular disease. Balata H; Blandin Knight S; Barber P; Colligan D; Crosbie EJ; Duerden R; Elton P; Evison M; Greaves M; Howells J; Irion K; Karunaratne D; Kirwan M; Macnab A; Mellor S; Miller C; Newton T; Novasio J; Sawyer R; Sharman A; Slevin K; Smith E; Taylor B; Taylor S; Tonge J; Walsham A; Waplington S; Whittaker J; Booton R; Crosbie PAJ Lung Cancer; 2018 Oct; 124():148-153. PubMed ID: 30268454 [TBL] [Abstract][Full Text] [Related]
23. European and US Guideline-Based Statin Eligibility, Genetically Predicted Coronary Artery Disease, and the Risk of Major Coronary Events. Park H; Kim D; You SC; Jang E; Yu HT; Kim TH; Kim DM; Sung JH; Pak HN; Lee MH; Yang PS; Joung B J Am Heart Assoc; 2024 May; 13(9):e032831. PubMed ID: 38639378 [TBL] [Abstract][Full Text] [Related]
24. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. Collins GS; Altman DG BMJ; 2010 May; 340():c2442. PubMed ID: 20466793 [TBL] [Abstract][Full Text] [Related]
25. Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease. Elliott J; Bodinier B; Bond TA; Chadeau-Hyam M; Evangelou E; Moons KGM; Dehghan A; Muller DC; Elliott P; Tzoulaki I JAMA; 2020 Feb; 323(7):636-645. PubMed ID: 32068818 [TBL] [Abstract][Full Text] [Related]
26. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries. Crowson CS; Gabriel SE; Semb AG; van Riel PLCM; Karpouzas G; Dessein PH; Hitchon C; Pascual-Ramos V; Kitas GD; Rheumatology (Oxford); 2017 Jul; 56(7):1102-1110. PubMed ID: 28339992 [TBL] [Abstract][Full Text] [Related]
28. Clinical use of polygenic risk scores for detection of peripheral artery disease and cardiovascular events. Omiye JA; Ghanzouri I; Lopez I; Wang F; Cabot J; Amal S; Ye J; Lopez NG; Adebayo-Tijani F; Ross EG PLoS One; 2024; 19(5):e0303610. PubMed ID: 38758931 [TBL] [Abstract][Full Text] [Related]
29. Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk-Enhancing Factor in the Pooled Cohort Equation: A Cost-Effectiveness Analysis Study. Mujwara D; Henno G; Vernon ST; Peng S; Di Domenico P; Schroeder B; Busby GB; Figtree GA; Bottà G J Am Heart Assoc; 2022 Jun; 11(12):e025236. PubMed ID: 35699184 [TBL] [Abstract][Full Text] [Related]
30. Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses. Garg N; Muduli SK; Kapoor A; Tewari S; Kumar S; Khanna R; Goel PK Indian Heart J; 2017; 69(4):458-463. PubMed ID: 28822511 [TBL] [Abstract][Full Text] [Related]
31. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial. Damask A; Steg PG; Schwartz GG; Szarek M; Hagström E; Badimon L; Chapman MJ; Boileau C; Tsimikas S; Ginsberg HN; Banerjee P; Manvelian G; Pordy R; Hess S; Overton JD; Lotta LA; Yancopoulos GD; Abecasis GR; Baras A; Paulding C; Circulation; 2020 Feb; 141(8):624-636. PubMed ID: 31707832 [TBL] [Abstract][Full Text] [Related]
32. Prediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk? van Staa TP; Gulliford M; Ng ES; Goldacre B; Smeeth L PLoS One; 2014; 9(10):e106455. PubMed ID: 25271417 [TBL] [Abstract][Full Text] [Related]
33. Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index. Khera R; Pandey A; Ayers CR; Carnethon MR; Greenland P; Ndumele CE; Nambi V; Seliger SL; Chaves PHM; Safford MM; Cushman M; Xanthakis V; Vasan RS; Mentz RJ; Correa A; Lloyd-Jones DM; Berry JD; de Lemos JA; Neeland IJ JAMA Netw Open; 2020 Oct; 3(10):e2023242. PubMed ID: 33119108 [TBL] [Abstract][Full Text] [Related]
34. Variation in cardiovascular disease risk factors among older adults in the Hunter Community Study cohort: A comparison of diet quality versus polygenic risk score. Reay WR; Haslam R; Cairns MJ; Moschonis G; Clarke E; Attia J; Collins CE J Hum Nutr Diet; 2022 Aug; 35(4):675-688. PubMed ID: 35560851 [TBL] [Abstract][Full Text] [Related]
35. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study. Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J Elife; 2023 Mar; 12():. PubMed ID: 36971353 [TBL] [Abstract][Full Text] [Related]
36. The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study. Hadaegh F; Asgari S; Moosaie F; Orangi M; Sarvghadi F; Khalili D; Azizi F J Transl Med; 2021 Jan; 19(1):25. PubMed ID: 33407576 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of the uptake and delivery of the NHS Health Check programme in England, using primary care data from 9.5 million people: a cross-sectional study. Patel R; Barnard S; Thompson K; Lagord C; Clegg E; Worrall R; Evans T; Carter S; Flowers J; Roberts D; Nuttall M; Samani NJ; Robson J; Kearney M; Deanfield J; Waterall J BMJ Open; 2020 Nov; 10(11):e042963. PubMed ID: 33154064 [TBL] [Abstract][Full Text] [Related]
38. Polygenic risk score for blood pressure and lifestyle factors with overall and CVD mortality: a prospective cohort study in a Japanese population. Fujii R; Hishida A; Nakatochi M; Okumiyama H; Takashima N; Tsuboi Y; Suzuki K; Ikezaki H; Shimanoe C; Kato Y; Tamura T; Ito H; Michihata N; Tanoue S; Suzuki S; Kuriki K; Kadota A; Watanabe T; Momozawa Y; Wakai K; Matsuo K; Hypertens Res; 2024 Sep; 47(9):2284-2294. PubMed ID: 38961281 [TBL] [Abstract][Full Text] [Related]
39. Evaluating cardiovascular disease risk stratification using multiple-polygenic risk scores and pooled cohort equations: insights from a 17-year longitudinal Korean cohort study. Park YS; Jang HM; Park JH; Kim BJ; Park HY; Kim YJ Front Genet; 2024; 15():1364993. PubMed ID: 38606355 [TBL] [Abstract][Full Text] [Related]
40. Lipidomic risk scores are independent of polygenic risk scores and can predict incidence of diabetes and cardiovascular disease in a large population cohort. Lauber C; Gerl MJ; Klose C; Ottosson F; Melander O; Simons K PLoS Biol; 2022 Mar; 20(3):e3001561. PubMed ID: 35239643 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]